FDA Narrows Guidance On New Alzheimer's Drug Amid Criticism

The transcript discusses the controversy surrounding a newly approved Alzheimer's drug. Health experts express skepticism about its effectiveness, while the FDA recommends it only for those with mild memory issues. This is the first Alzheimer's drug approved in 18 years, and while patient groups are eager for its approval, many experts, including the FDA's advisory committee, remain unconvinced of its efficacy.

What was the reaction of groups representing Alzheimer's patients to the FDA's decision?

What was the stance of the FDA's Independent Advisory committee regarding the drug's effectiveness?